Search

Your search keyword '"O31"' showing total 761 results

Search Constraints

Start Over You searched for: "O31" Remove constraint "O31" Search Limiters Full Text Remove constraint Search Limiters: Full Text Language undetermined Remove constraint Language: undetermined
761 results on '"O31"'

Search Results

1. O31: Risk allele evidence curation, classification, and reporting: Recommendations from the ClinGen Low Penetrance/Risk Allele Working Group*

2. O31 SUTURE OR MESH REPAIR FOR THE SMALLEST UMBILICAL HERNIAS: A NATIONWIDE DATABASE STUDY

3. O31 Giant cell arteritis - a rare ocular presentation

4. O31 Central venous access in ventilated COVID-19 patients: a vascular surgery perspective

5. O31 Trajectories of anxiety in children young people and adults with rheumatic diseases in the wake of COVID-19: results from the COVID-19 European patient registry

6. O31: CORRELATION BETWEEN THYROID FINE NEEDLE ASPIRATION CYTOLOGY (FNAC) SCORES AND CANCER INCIDENCE ON FINAL HISTOPATHOLOGY – A MULTI-CENTRE RETROSPECTIVE ANALYSIS

8. O31 Determining Low-Income Fathers’ Preferred mHealth Nutrition-Related Topics, Features, and Delivery Methods

9. O31 IL-27 regulates the magnitude of ectopic germinal centres in experimental sialadenitis but fails to modulate IL-17 and IFNg production in CD4 T cells from patients with Sjögren's syndrome

10. O31 Integrative analysis reveals a molecular stratification of systemic autoimmune diseases

13. O31 Therapeutic itineraries and childhood cancer in argentina: peripheral perspectives

14. O31 Evaluating Success of Paraprofessional Educators in a Pilot Adolescent Classroom Intervention: Rev It Up!

16. O31 Levetiracetam monitoring in breast-milk: high inter-individual variability

18. O31. Gout and Risk of Subsequent Vascular Event: A Discrete-Time Event History Analysis in the Clinical Practice Research Datalink

20. Structure of the O-polysaccharide of Proteus penneri 28 and Proteus vulgaris O31 and classification of P. penneri 26 and 28 in Proteus serogroup O31

21. Genetic variation of capsule/LPS biogenesis in two serogroup O31 Vibrio cholerae isolates

22. O31 Menses – to test or not to test?: Abstract O30 Table 1

23. O31. An Open Label, Pilot, Multi-Centre, Step-Down, Randomized Controlled Trial to Examine Whether Etanercept 25 mg Once Weekly is Effective in Maintaining a Clinical Response in Patients with Ankylosing Spondylitis who have Responded to 50 mg Once Weekly

24. O31: Array-MAPH: a novel microarray technology for genomic analysis

26. O31 The prevalence and impact of fibromyalgia in rheumatoid arthritis

27. Optimal Selection of Parameters for Production of Multiwall Carbon Nanotubes (MWCNTs) by Electrolysis in Molten Salts using Machine Learning

28. Mathematical Analysis in Characterization of Carbon Nanotubes (CNTs) as possible Mosquito Repellents

29. Disruptive Innovation & Chance for Latecomer Firms in E-Commerce: The Cases of the YES and PINDUODUO

30. Innovationspolitik in der neuen Legislaturperiode: eine neue strategische Ausrichtung?

31. Understanding the robotization landscape transformation: A centering resonance analysis

32. Sources of innovation: Consequences for knowledge production and transfer

33. Stepping up to the mark? Firms’ export activity and environmental innovation in 14 European countries

34. The Influence of Public Support for Innovations on the Economic Performance of Enterprises

35. Augmented Reality and Virtual Reality-Based Technology in Cultural Tourism

36. Applying Principles of Management Innovation in Advertising Agencies

37. Innovation and economic crisis in transition economies

38. Fintech Innovation in the Financial Sector: Influence of E-Money Products on a Growing Economy

39. Globalisierung von Forschung und Entwicklung der weltweit forschungsstärksten Unternehmen

40. Organizational Factors of Innovativeness in Serbian Enterprises

41. Adaptability of Securitization Model to Conditions of Volatile Financial Structure

42. The Effect of External Knowledge Sources on Organizational Innovation in Small and Medium Enterprises in Germany

43. ResTech: innovative technologies for crisis resolution

44. Twenty years of US nanopatenting: Maintenance renewal scoring as an indicator of patent value

45. THE MOTIVATION FOR ENGINEERING CHANGE IN THE INDUSTRIAL COMPANY

46. Re-Strategising Government Palliative Support Systems in Tackling the Challenges of COVID-19 Lockdown in Lagos State, Nigeria

47. Une expérience sur la contribution volontaire à une réseau académique sur la PAC. Une note

48. The economic impact of streaming beyond GDP

49. Economic Activity and the Value of Medical Innovation during a Pandemic

50. Financial modelling, risk management of energy instruments and the role of cryptocurrencies

Catalog

Books, media, physical & digital resources